Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP

Transplant of HIP-modified pancreatic islet cells provided lasting glucose control in a fully immunocompetent non-human primate , enabling the achievement of exogenous insulin independence without...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Nicole Keith ,Sonja Schrepfer ,Sanjoy Dutta ,Sana Biotechnology Inc ,Rd Fund ,Nasdaq ,Cell Stem ,South San Francisco ,Sana Biotechnology ,Quarterly Report ,Markets ,